ABRAHAM RAMOS

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology MIAMI, FL NPI 1962846758

General Payments — all program years on this page

$848.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $466.04 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $441.4319
Education $24.611

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $57.202
2019 $325.078
2024 $466.0420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086108460 Bayer Healthcare Pharmaceuticals Inc. $23.71 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086179522 Bayer Healthcare Pharmaceuticals Inc. $23.27 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104606684 AstraZeneca Pharmaceuticals LP $25.00 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104783044 AstraZeneca Pharmaceuticals LP $20.91 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105253949 AstraZeneca Pharmaceuticals LP $24.28 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111683451 Amgen Inc. $26.96 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848748 OPKO Pharmaceuticals, LLC $20.00 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112848750 OPKO Pharmaceuticals, LLC $18.33 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118966485 Otsuka America Pharmaceutical, Inc. $22.31 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118966487 Otsuka America Pharmaceutical, Inc. $24.86 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127023876 Kyowa Kirin, Inc. $27.94 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141509971 CALLIDITAS THERAPEUTICS US INC. $20.86 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141528843 CALLIDITAS THERAPEUTICS US INC. $21.45 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145828230 AKEBIA THERAPEUTICS INC $22.01 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832877 AKEBIA THERAPEUTICS INC $24.61 08/23/2024 Education Undisputed 01/23/2026 View at CMS
1146702686 Ardelyx, Inc. $20.00 05/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146702688 Ardelyx, Inc. $25.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690203 Aurinia Pharma U.S., Inc. $26.52 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150690205 Aurinia Pharma U.S., Inc. $28.58 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154200368 Fresenius USA Marketing, Inc. $19.44 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.